ketoconazole has been researched along with Hepatic Veno Occlusive Disease in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risk factors for hepatic veno-occlusive disease (HVOD) were analysed in a population of 136 autografted children who received high-dose busulfan (BU) as part of a conditioning regimen." | 7.68 | Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. ( Benhamou, E; Brugieres, L; Hartmann, O; Lemerle, J; Méresse, V; Valteau-Couanet, D; Vassal, G, 1992) |
| "Risk factors for hepatic veno-occlusive disease (HVOD) were analysed in a population of 136 autografted children who received high-dose busulfan (BU) as part of a conditioning regimen." | 3.68 | Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. ( Benhamou, E; Brugieres, L; Hartmann, O; Lemerle, J; Méresse, V; Valteau-Couanet, D; Vassal, G, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaufmann, P | 1 |
| Haschke, M | 1 |
| Török, M | 1 |
| Beltinger, J | 1 |
| Bogman, K | 1 |
| Wenk, M | 1 |
| Terracciano, L | 1 |
| Krähenbühl, S | 1 |
| Méresse, V | 1 |
| Hartmann, O | 1 |
| Vassal, G | 1 |
| Benhamou, E | 1 |
| Valteau-Couanet, D | 1 |
| Brugieres, L | 1 |
| Lemerle, J | 1 |
2 other studies available for ketoconazole and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Line, T | 2006 |
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Female; Hepatic Veno-Occ | 1992 |